FILTER

Refine your search with the following facets to narrow down your results.

7 Current news of Med BioGene

Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia

21-Mar-2007 - Med BioGene Inc. announced that it has entered into a research collaboration and option agreement with Duke University to further develop and validate MBI's genetic biomarkers for lymphoma and leukemia using its Gene Expression Profiling SystemTM. The collaboration between MBI and Duke includes, ...

biomarkers gene expression leukemia +3

Med BioGene Receives Funding from National Research Council Canada to Develop Genetic Biomarkers for Cardiovascular Disease

12-Mar-2007 - Med BioGene Inc. announced that it has received a $307,000 contribution from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to develop genetic biomarkers for cardiovascular disease (CVD). "We believe that Med BioGene's expertise in gene expression and the ...

biomarkers cardiovascular diseases gene expression +1

Med BioGene Appoints Dr. Richard C. Cook to its Scientific Advisory Board

05-Mar-2007 - Med BioGene Inc. announced that it has appointed Dr. Richard C. Cook, MD, M.Sc., FRCSC, to its Scientific Advisory Board. Dr. Cook is a Clinical Associate Professor of Surgery with the Department of Cardiovascular Surgery at the University of British Columbia and is an expert in complex mitral ...

cardiothoracic surgery cardiovascular surgery Scientific Advisory Boards +2

Med BioGene announces futher promising results on the diagnostic value of its lymphoma genetic biomarkers

05-Feb-2007 - Med BioGene Inc. announced the results of its latest pre-clinical studies involving its Gene Expression Profiling System(TM) for diagnosing lymphoma. 110 RNA samples derived from human lymphoma tissues, representing the seven major subtypes of lymphoma, were analyzed utilizing a 10-fold ...

biomarkers clinical trials gene expression +3

Med BioGene reports pre-clinical results of its Diagnostic Lymphoma DNA Bioarray

08-Aug-2006 - Med BioGene Inc. announced the results of its pre-clinical studies involving its Diagnostic Lymphoma Bioarray. The studies of fifty RNA samples derived from human lymphoma tissues suggest that MBI's Diagnostic Lymphoma Bioarray successfully differentiated between genes in both the diseased and ...

clinical trials Expression lymphoma +1

Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director

23-May-2006 - Med BioGene Inc. (MBI) announced the appointment of Erinn B. Broshko as Chief Executive Officer and a director of MBI. Prior to joining MBI, Mr. Broshko was a corporate and securities lawyer with the Vancouver law firm of Farris, Vaughan, Wills & Murphy LLP. Mr. Broshko's legal practice was ...

biotechnology

Med BioGene Inc. completes acquisition of Dragon-Tex (Group) Limited and $2 million financing

09-May-2006 - Med BioGene Inc. announced that it completed its acquisition of Dragon-Tex (Group) Limited ("DTX"). As part of the acquisition, the shareholders of DTX exchanged their common shares for common shares of MBI on the basis of two common shares of DTX for one common share of MBI. Furthermore, ...